InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,564.41
(
0.00%
)
US TECH 100
19,236.00
(
-0.36%
)
Dow Jones
40,415.44
(
0.00%
)
Brent Oil
80.93
(
-0.72%
)
Bitcoin
66,463.61
(
-1.69%
)
Post# of 252650
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 85586

Wednesday, 11/04/2009 3:05:13 AM

Wednesday, November 04, 2009 3:05:13 AM

Post# of 252650
IDIX has initiated a Phase II clinical trial evaluating IDX184+ SoC for 14 days and doses of up to 200mg (Patients will continue on treatment with pegylated interferon and ribavirin for 14 more days):

http://finance.yahoo.com/news/Idenix-Pharmaceuticals-prnews-2318795928.html/print?x=0
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up